BHB-T cells
Recruiting
18 years - 99 years
All
Phase
N/A
20 participants needed
1 Location
Brief description of study
The aim of this study is to biobank blood and
stool samples of healthy individuals receiving β-hydroxybutyrate (BHB)
supplementation. Additionally, this study will determine whether BHB
supplementation increases serum BHB levels and leads to changes in T cell
phenotype, including composition (i.e. CD4/CD8), and cytokine secretion. BHB
supplementation will be performed through oral administration of HVMN
Ketone-IQ, a commercially available BHB supplement, with an active ingredient
of R-1,3-Butanediol, which gets converted to BHB.
Detailed description of study
This is a preliminary study to biobank blood and
stool samples following oral BHB supplementation in healthy subjects
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 18 years - 99 years
-
Gender: All
1.1 Inclusion Criteria
·
Age of
18 years or older
·
Can provide informed consent.
1.2 Exclusion Criteria
- Subject is pregnant, a prisoner, or is under 18 years of age.
- Subject is actively breastfeeding
- History of autoimmune disease
- History of inflammatory bowel disease
- History of diabetes mellitus and are currently on medical diabetes therapy
- History of chronic kidney disease with an eGFR < 60 mL/min/1.73m2
- Cancer diagnosis where the subject is receiving active therapy, or cancer history within 5 years (non-melanoma skin cancers are not exclusion criteria)
- Use of either a ketogenic diet or intermittent fasting (defined as a fasting period of 16 hours or more per day that is not associated with a medical procedure) during the 4 weeks prior to enrollment.
Updated on
17 Jun 2025.
Study ID: 24-0763
Find a site
,
Your Information has been sent successfully.
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or